Indicator | Target |
Screening rate: target population Dschang ~10 000 women, 30–49 years | 2000 per year |
Percentage of women having completed the single-visit 3T-approach | ≥90% |
Percentage of HPV-positive women | 18–25% |
Percentage of HPV-positive women who received VIA/VILI | >95% |
Percentage of VIA/VILI-positive cases | 40–55% |
Percentage of VIA/VILI-positive cases who received treatment | ≥90% |
Follow-up rate after treatment: 1 month, 6 months, 12 months | ≥80%, ≥70%, ≥70% |
Major incident rate during or after thermoablation or LEEP | <1% |
Percentage of HPV-positive women VIA/VILI-negative returned for a control | ≥70% |
HPV, human papillomavirus; LEEP, loop electrosurgical excision procedure; VIA/VILI, visual inspection with acetic acid/visual inspection with Lugol's iodine.